Ken Fisher’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Ken Fisher’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-53,892	Closed	-$1.79M	–	899
2020 Q2	$1.79M	Sell	53,892 -12,967	-19%	-$413K	﹤0.01%	499
2020 Q1	$1.82M	Sell	66,859 -6,842	-9%	-$190K	﹤0.01%	455
2019 Q4	$1.45M	Hold	73,701	–	–	﹤0.01%	540
2019 Q3	$955K	Hold	73,701	–	–	﹤0.01%	614
2019 Q2	$918K	Hold	73,701	–	–	﹤0.01%	607
2019 Q1	$1.07M	Hold	73,701	–	–	﹤0.01%	581
2018 Q4	$814K	Buy	73,701 +8,176	+12%	+$114K	﹤0.01%	610
2018 Q3	$1.72M	Sell	65,525 -28,407	-30%	-$768K	﹤0.01%	536
2018 Q2	$1.92M	Sell	93,932 -27,575	-23%	-$592K	﹤0.01%	535
2018 Q1	$2.21M	Sell	121,507 -3,000	-2%	-$50K	﹤0.01%	516
2017 Q4	$1.74M	Buy	124,507 +25,984	+26%	+$351K	﹤0.01%	535
2017 Q3	$1.82M	Buy	+98,523	New	+$1.65M	﹤0.01%	514

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Ken Fisher's MNTA Position: Q3 2020 in Review

Ken Fisher sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 53,892 shares — an estimated $1.79M sold.

Ken Fisher first reported a position in MNTA in Q3 2017 and held it in 12 quarters. The position peaked at $2.21M in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Ken Fisher reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Ken Fisher sold 53,892 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.79M.
Ken Fisher first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2017 and held it in 12 quarters.
Ken Fisher's Momenta Pharmaceuticals, Inc. position peaked at $2.21M in Q1 2018.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Fisher Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.